(AEGR) (GEVA) (MACK) (SUPN) (XOMA) (ZGNX) to be Added to NASDAQ Biotechnology Index (IBB)
Get Alerts AEGR Hot Sheet
Join SI Premium – FREE
The NASDAQ OMX Group announced that Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), Synageva BioPharma Corp. (Nasdaq: GEVA), Merrimack Pharmaceuticals, Inc.(Nasdaq: MACK), Supernus Pharmaceuticals, Inc.(Nasdaq: SUPN), XOMA Corporation (Nasdaq: XOMA) and Zogenix, Inc. (Nasdaq: ZGNX) will be added to NASDAQ Biotechnology Index effective prior to market open on Monday, November 19, 2012.
Maxygen, Inc. (Nasdaq: MAXY) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) will be removed from the index.
Related ETF: iShares Nasdaq Biotechnology (NASDAQ: IBB).
Maxygen, Inc. (Nasdaq: MAXY) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) will be removed from the index.
Related ETF: iShares Nasdaq Biotechnology (NASDAQ: IBB).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XPeng Inc. (XPEV) Terminates Relevant Agreement with Taobao China
- Boj To End Yield Curve Control, ETF Purchases Tuesday - Nikkei
- US Energy Department Set To Unveil Final Rules On Tuesday That Will Soften Proposal To Slash Electric Vehicle Mileage Ratings To Meet Fuel Economy Rules - Reuters
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!